“Increased Plasma Lipocalin-2 Levels Correlate With Disease Severity and May Be a Marker of Acute Inflammatory Response in Patients With Psoriasis”. 2022. Dermatology Reports 14 (4). https://doi.org/10.4081/dr.2022.9469.